A critical breakthrough in cancer study is occurring with the use of nanobodies to reactivate damaged p53. This vital malignant protector protein is frequently disabled in various types of malignancies, resulting https://bookmark-dofollow.com/story29823416/mini-antibodies-revive-the-p53-protein-the-promising-pathway-for-malignant-management